Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $7.60 in the prior trading day, Amneal Pharmaceuticals Inc (NASDAQ: AMRX) closed at $7.43, down -2.24%. In other words, the price has decreased by -$2.24 from its previous closing price. On the day, 1.04 million shares were traded. AMRX stock price reached its highest trading level at $7.735 during the session, while it also had its lowest trading level at $7.38.
Ratios:
Our goal is to gain a better understanding of AMRX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.97 and its Current Ratio is at 1.65.
On March 08, 2021, Goldman Upgraded its rating to Buy which previously was Sell and also upped its target price recommendation from $4 to $6.50.
Guggenheim Upgraded its Neutral to Buy on December 14, 2020, while the target price for the stock was maintained at $5.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 17 ’24 when Autor Deborah M. sold 23,447 shares for $6.73 per share. The transaction valued at 157,728 led to the insider holds 93,402 shares of the business.
Autor Deborah M. sold 14,553 shares of AMRX for $98,378 on May 16 ’24. The Director now owns 116,849 shares after completing the transaction at $6.76 per share. On Aug 11 ’23, another insider, BOYER ANDREW S, who serves as the Executive Vice President of the company, sold 29,302 shares for $4.13 each. As a result, the insider received 120,921 and left with 244,739 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMRX now has a Market Capitalization of 2348912896 and an Enterprise Value of 5037770752. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.92 while its Price-to-Book (P/B) ratio in mrq is 115.16. Its current Enterprise Value per Revenue stands at 2.019 whereas that against EBITDA is 9.41.
Stock Price History:
Over the past 52 weeks, AMRX has reached a high of $7.65, while it has fallen to a 52-week low of $2.99. The 50-Day Moving Average of the stock is 10.00%, while the 200-Day Moving Average is calculated to be 33.92%.
Shares Statistics:
The stock has traded on average 1.55M shares per day over the past 3-months and 1107900 shares per day over the last 10 days, according to various share statistics. A total of 306.56M shares are outstanding, with a floating share count of 111.14M. Insiders hold about 63.99% of the company’s shares, while institutions hold 27.21% stake in the company. Shares short for AMRX as of 1719532800 were 4520585 with a Short Ratio of 2.92, compared to 1717113600 on 3608303. Therefore, it implies a Short% of Shares Outstanding of 4520585 and a Short% of Float of 1.76.
